In breast cancer cells, reduced SCN4B expression is associated with increased RhoA activity, enhanced cell migration and invasiveness, primary tumor growth and metastatic spreading, via promoting the acquisition of an amoeboid-mesenchymal hybrid phenotype [6]. This evidence concerns the gene SCN4B and neoplasm.